bpc-157 wolverine stack / TB-500 BPC-157 Peptide Pen 10mg |

The information contained on this site is general in nature and is intended for use as an informational aid

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions

I believe I have been under treated for pernicious anaemia for many years and last year decided to

Avoid freezing the reconstituted solution

The COA documents purity (HPLC), molecular identity (mass spectrometry), and testing methodology

The compounds mechanism of action makes it relevant to research on metabolic disorders, obesity, and energy metabolism